// App-Quantinova.ai

P7.02 : The clinical potential of ARGX-111, an afucosylated anti-MET antibody, in hematological malignancies and suppression of metastasis

Researchers

Presenter

  • V. Hanssens

Principal Investigators

  • N. De Jonge

  • A. Hultberg

  • C. Borg

  • P. Michieli

  • T. Dreier

  • H. de Haard

  • A. Thibault

Medical Centers

  • University Hospital of Besancon, Besancon, France

  • Argen-X, Zwijnaarde, BelgiumCandiolo Cancer Institute - Fpo, IRCCS, Candiolo, Turin, Italy

Locations

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • ARGX-111

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved